RE:RE:RE:RE:The best competition has to offer If 13, 14 and their successors mimic 5 & 6 there may not even need to be a second treatment, just a precautionary cystoscopy at 6 months to ensure that there remains ‘no clinical evidence or presence of disease’.
Contrast this with the cost and logistical burden on public health and the detriment to the well-being of often elderly and unwell patients that accompany the many instillations of this competitor’s combination therapy and equivalents.
If we can achieve similar or better enduring CRs there should be no contest IMHO.